TrialThe Journal of clinical investigation2021

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.

Mark Yarchoan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.